First human tests begin for new oral drug candidate
NCT ID NCT06741345
Summary
This early-stage study aimed to check the safety of a new oral liquid drug called BIO 300 and learn how the body absorbs and processes it. It involved 56 healthy volunteers who took the drug daily for two weeks at different doses. A second part tested whether taking the drug with or without food changes how it works in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER STUDY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nucleus Network, LLC
Saint Paul, Minnesota, 55114, United States
Conditions
Explore the condition pages connected to this study.